Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 5/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 4/20 | 1.00 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.76 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.69 |
| ▸ | BLM | P54132 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.64 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.60 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylhomatropine SCHEMBL17179980 | 1.00 | CHRM2 (1.00) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Methylhomatropine SCHEMBL16784195 | 1.00 | CHRM2 (1.00) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Methylhomatropine SCHEMBL20659943 | 0.99 | CHRM2 (0.97) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Methylhomatropine SCHEMBL29555824 | 0.99 | CHRM2 (0.97) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Methylhomatropine SCHEMBL77827 | 0.99 | CHRM2 (0.97) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Methylhomatropine SCHEMBL613580 | 0.99 | CHRM2 (0.97) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Phenactropinium SCHEMBL29387827 | 0.83 | CHRM2 (0.70) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Phenactropinium SCHEMBL8916468 | 0.83 | CHRM2 (0.70) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Methylatropine SCHEMBL34463463 | 0.83 | CHRM2 (1.00) | CHRM2CHRM1PABPC1CHRM3BLM | |
| Methylatropine SCHEMBL824874 | 0.83 | CHRM2 (1.00) | CHRM2CHRM1PABPC1CHRM3BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11752086-B2 | Topical formulations and methods | MYOCEPT INC. (US) | 2023-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11752086-B2 | Topical formulations and methods | KRT18, ANXA3, VIP | CHRM2 3496/4885CHRM1 3820/4885PABPC1 2874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.